{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:09:08Z","timestamp":1787317748229,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundaci\u00f3n Universitaria San Pablo CEU \u2013 Banco Santander","award":["FUSP-BS-PPC-USP02\/2017"],"award-info":[{"award-number":["FUSP-BS-PPC-USP02\/2017"]}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2020-114343GA-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2020-114343GA-I00\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The term \u201cmetabolically healthy obesity\u201d is used to define those patients with obesity that do not present elements of metabolic syndrome. The causes behind this temporary reduction of the cardiovascular risk are still unknown, although these patients are characterized by a conserved expansion capacity of the adipose tissue, preventing ectopic accumulation of fat. Since hormones are key regulators in adipogenesis, we hypothesize that there are sex-specific differences in visceral white adipose tissue (vWAT) biology that may contribute to metabolic health disparities between men and women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>60 patients attending the Morbid Obesity Unit from the Hospital Universitario de Getafe for elective bariatric surgery were enrolled. Prior to the surgery, a full biochemical panel was carried out. During the procedure, a portion of vWAT was excised and snap-frozen for histological analysis and for the study of the transcriptomic fingerprint in 8 metabolically healthy (MH) and 8 metabolically unhealthy (MU) patients using a transcript expression microarray. The results were validated by qPCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Functional enrichment analysis of the differentially expressed transcripts (DETs) revealed a similar vWAT transcriptome between MH and MU patients, with differences related to immune response and metabolism homeostasis. However, when we stratified the patients by sex, the number of DETs multiplied by 10, showing sex-specific signatures. MH men presented a reduced pro-inflammatory and oxidative stress profile in comparison to MU men. Thus, the transition from MH to a MU state in men led to a disruption of the normal biology of the tissue, which correlates to the apparition of comorbidities. Surprisingly, MH females exhibited the most deleterious profile, with alterations of key pathways related to inflammation, extracellular matrix organization and metabolism in comparison to MU females. Even those common processes (extracellular remodeling and inflammation) that were observed in men and women cohorts presented a unique signature. These results suggest that vWAT in females suffers an exaggerated pathological state in response to the increased demand to store energy in comparison to men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that obesity should be treated as a different entity in men and women and highlight the need of early intervention in female patients with obesity, even in the absence of comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain english summary<\/jats:title>\n                    <jats:p>Obesity is often linked to metabolic problems, but some patients with obesity do not show typical signs of metabolic syndrome, a situation referred to as \"metabolically healthy obesity.\" The reasons behind this are not fully understood, but it is thought that these individuals have healthier adipose tissue that prevents the accumulation of fat in other organs. Since hormones play an important role in fat storage, we examined if there are gender differences in how adipose tissue responds to fat accumulation. In this study, we analyzed the genes that were expressed in the visceral adipose tissue of patients with obesity who were metabolically healthy (MH) and those who were metabolically unhealthy (MU). When we compared the results, we found that men and women had different gene activity patterns. For men, MH adipose tissue had less inflammation and stress compared to MU adipose tissue. However, MH women tissue showed worse signs of inflammation, fibrosis and metabolism problems than MU women. Between genders, there are several differences in the pathways that are triggered by obesity, with women having a more pathological profile. Even those processes that were common had a worst profile than in men. This suggests that women adipose tissue does not adapt equally to the increased demand for energy storage, even in the absence of metabolic abnormalities. These results suggest that obesity should be treated differently in men and women and emphasize the importance of early intervention for women, even if they do not show metabolic alterations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-025-00777-6","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:49:30Z","timestamp":1762440570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding the role of visceral fat in metabolically healthy versus unhealthy obesity: a sex-based analysis of the transcriptome"],"prefix":"10.1186","volume":"16","author":[{"given":"Mar\u00eda","family":"Calder\u00f3n-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"S\u00e1nchez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Gonz\u00e1lez-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gil-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Somoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Arroyo-Solera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Valverde-Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Larriva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Miguel","family":"C\u00e1rdenas-Rebollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Ruiz de Adana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"777_CR1","doi-asserted-by":"crossref","unstructured":"Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022 Sep 20 [cited 2025 Feb 13]:7(9):e009773. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9494015\/","DOI":"10.1136\/bmjgh-2022-009773"},{"key":"777_CR2","unstructured":"Bentham J, Di Cesare M, Bilano V, Bixby H, Zhou B, Stevens GA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. The Lancet. 2017 Dec 16 [cited 2025 Feb 13];390(10113):2627\u201342. Available from: http:\/\/www.thelancet.com\/article\/S0140673617321293\/fulltext"},{"key":"777_CR3","doi-asserted-by":"crossref","unstructured":"Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016 Feb 1 [cited 2023 Apr 21];17(2):95\u2013107. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26696565\/","DOI":"10.1111\/obr.12334"},{"key":"777_CR4","doi-asserted-by":"crossref","unstructured":"Sahoo K, Sahoo B, Choudhury A, Sofi N, Kumar R, Bhadoria A. Childhood obesity: causes and consequences. J Family Med Prim Care. 2015 [cited 2023 Apr 21];4(2):187. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25949965\/","DOI":"10.4103\/2249-4863.154628"},{"key":"777_CR5","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M. The distinction of metabolically \u201chealthy\u201d from \u201cunhealthy\u201d obese individuals. Curr Opin Lipidol. 2010 Feb [cited 2023 Apr 21];21(1):38\u201343. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19915462\/","DOI":"10.1097\/MOL.0b013e3283346ccc"},{"key":"777_CR6","doi-asserted-by":"crossref","unstructured":"Liu M, Wang P, Xie P, Xu X, He L, Chen X, et al. Expression of ICAM-1 and E-selectin in different metabolic obesity phenotypes: discrepancy for endothelial dysfunction. J Endocrinol Invest. 2023 Apr 18 [cited 2023 Apr 21]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37071373\/","DOI":"10.1007\/s40618-023-02094-4"},{"key":"777_CR7","doi-asserted-by":"crossref","unstructured":"Wei D, Gonz\u00e1lez-Marrachelli V, Melgarejo JD, Liao C Te, Hu A, Janssens S, et al. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study. Cardiovasc Diabetol. 2023 Apr 7 [cited 2023 Apr 21];22(1):82. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37029406\/","DOI":"10.1186\/s12933-023-01815-6"},{"key":"777_CR8","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M. Metabolically Healthy Obesity. Endocr Rev. 2020 Jun 1 [cited 2023 Apr 26];41(3):405\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32128581\/","DOI":"10.1210\/endrev\/bnaa004"},{"key":"777_CR9","doi-asserted-by":"crossref","unstructured":"Zhou Z, Macpherson J, Gray SR, Gill JMR, Welsh P, Celis-Morales C, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia. 2021 Sep 1 [cited 2023 Apr 21];64(9):1963\u201372. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34109441\/","DOI":"10.1007\/s00125-021-05484-6"},{"key":"777_CR10","doi-asserted-by":"crossref","unstructured":"Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018 Sep 1 [cited 2023 Apr 21];6(9):714\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29859908\/","DOI":"10.1016\/S2213-8587(18)30137-2"},{"key":"777_CR11","doi-asserted-by":"crossref","unstructured":"Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese PhenotypeA cohort study. Diabetes Care. 2013 Aug 1 [cited 2023 May 2];36(8):2388\u201394. Available from: https:\/\/diabetesjournals.org\/care\/article\/36\/8\/2388\/33208\/Diabetes-and-Cardiovascular-Disease-Outcomes-in","DOI":"10.2337\/dc12-1971"},{"key":"777_CR12","doi-asserted-by":"crossref","unstructured":"Netto AM, Kashiwagi NM, Minanni CA, Santos RD, Cesena FY. Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: Influences of age and sex. Nutr Metab Cardiovasc Dis. 2023 [cited 2023 May 2]; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37095017\/","DOI":"10.1016\/j.numecd.2023.03.020"},{"key":"777_CR13","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhu J, Kim JH, Sumerlin TS, Feng Q, Yu J. Metabolic health and adiposity transitions and risks of type 2 diabetes and cardiovascular diseases: a systematic review and meta-analysis. Diabetol Metab Syndr. 2023 Dec 1 [cited 2023 Apr 26];15(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36973730\/","DOI":"10.1186\/s13098-023-01025-w"},{"key":"777_CR14","doi-asserted-by":"crossref","unstructured":"Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, Saavedra-Pe\u00f1a R, et al. The Adipose Tissue Microenvironment Regulates Depot-Specific Adipogenesis in Obesity. Cell Metab. 2016 Jul 12 [cited 2025 Feb 13];24(1):142\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27320063\/","DOI":"10.1016\/j.cmet.2016.05.012"},{"key":"777_CR15","doi-asserted-by":"crossref","unstructured":"Steiner BM, Berry DC. The Regulation of Adipose Tissue Health by Estrogens. Front Endocrinol (Lausanne). 2022 May 26 [cited 2025 Feb 13];13:889923. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9204494\/","DOI":"10.3389\/fendo.2022.889923"},{"key":"777_CR16","doi-asserted-by":"crossref","unstructured":"Gershoni M, Pietrokovski S. The landscape of sex-differential transcriptome and its consequent selection in human adults. BMC Biol. 2017 Feb 7 [cited 2025 Feb 14];15(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28173793\/","DOI":"10.1186\/s12915-017-0352-z"},{"key":"777_CR17","doi-asserted-by":"crossref","unstructured":"Carobbio S, Pellegrinelli V, Vidal-Puig A. Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome. Adv Exp Med Biol. 2017 [cited 2023 Apr 26];960:161\u201396. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28585199\/","DOI":"10.1007\/978-3-319-48382-5_7"},{"key":"777_CR18","doi-asserted-by":"crossref","unstructured":"Carobbio S, Pellegrinelli V, Vidal-Puig A. Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome. Adv Exp Med Biol. 2017 [cited 2025 Feb 13];960:161\u201396. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28585199\/","DOI":"10.1007\/978-3-319-48382-5_7"},{"key":"777_CR19","doi-asserted-by":"crossref","unstructured":"Galarraga M, Campi\u00f3n J, Mun\u00f5z-Barrutia A, Boqu\u00e9 N, Moreno H, Mart\u00ednez JA, et al. Adiposoft: Automated software for the analysis of white adipose tissue cellularity in histological sections. J Lipid Res. 2012 Dec 1 [cited 2025 Feb 13];53(12):2791\u20136. Available from: http:\/\/www.jlr.org\/article\/S0022227520418139\/fulltext","DOI":"10.1194\/jlr.D023788"},{"key":"777_CR20","doi-asserted-by":"crossref","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 2012 9:7. 2012 Jun 28 [cited 2025 Feb 13];9(7):676\u201382. Available from: https:\/\/www.nature.com\/articles\/nmeth.2019","DOI":"10.1038\/nmeth.2019"},{"key":"777_CR21","doi-asserted-by":"crossref","unstructured":"Mongraw-Chaffin M, Foster MC, Anderson CAM, Burke GL, Haq N, Kalyani RR, et al. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk. J Am Coll Cardiol. 2018 May 1 [cited 2025 Feb 13];71(17):1857\u201365. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29699611\/","DOI":"10.1016\/j.jacc.2018.02.055"},{"key":"777_CR22","doi-asserted-by":"crossref","unstructured":"Lin H, Zhang L, Zheng R, Zheng Y. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article. Medicine. 2017 Nov 1 [cited 2025 Feb 13];96(47). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29381992\/","DOI":"10.1097\/MD.0000000000008838"},{"key":"777_CR23","doi-asserted-by":"crossref","unstructured":"Netto AM, Kashiwagi NM, Minanni CA, Santos RD, Cesena FY. Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: Influences of age and sex. Nutr Metab Cardiovasc Dis. 2023 Jun 1 [cited 2025 Jul 7];33(6):1149\u201357. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37095017\/","DOI":"10.1016\/j.numecd.2023.03.020"},{"key":"777_CR24","doi-asserted-by":"crossref","unstructured":"Mendes FD, dos Santos HC, Mill JG, Molina MDCB, de F\u00e1tima Sander Diniz MH, Quintino CR, et al. From healthy to unhealthy obesity: A longitudinal study of adults in ELSA-Brasil. PLOS global public health. 2025 Apr 1 [cited 2025 Jul 7];5(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40299945\/","DOI":"10.1371\/journal.pgph.0004325"},{"key":"777_CR25","doi-asserted-by":"crossref","unstructured":"Kouvari M, M. DCunha N, Tsiampalis T, Zec M, Sergi D, Travica N, et al. Metabolically Healthy Overweight and Obesity, Transition to Metabolically Unhealthy Status and Cognitive Function: Results from the Framingham Offspring Study. Nutrients. 2023 Mar 1 [cited 2025 Jul 7];15(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36904288\/","DOI":"10.3390\/nu15051289"},{"key":"777_CR26","doi-asserted-by":"crossref","unstructured":"Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013 [cited 2025 Feb 13];36(8):2388\u201394. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23491523\/","DOI":"10.2337\/dc12-1971"},{"key":"777_CR27","doi-asserted-by":"crossref","unstructured":"Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018 Sep 1 [cited 2025 Feb 13];6(9):714\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29859908\/","DOI":"10.1016\/S2213-8587(18)30137-2"},{"key":"777_CR28","doi-asserted-by":"crossref","unstructured":"Rosendo-Silva D, Gomes PB, Rodrigues T, Viana S, da Costa AN, Scherer PE, et al. Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction. Metabolism. 2024 Apr 1 [cited 2025 Feb 13];153. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38219974\/","DOI":"10.1016\/j.metabol.2024.155788"},{"key":"777_CR29","doi-asserted-by":"crossref","unstructured":"Kogelman LJA, Fu J, Franke L, Greve JW, Hofker M, Rensen SS, et al. Inter-Tissue Gene Co-Expression Networks between Metabolically Healthy and Unhealthy Obese Individuals. PLoS One. 2016 Dec 1 [cited 2025 Feb 13];11(12). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27907186\/","DOI":"10.1371\/journal.pone.0167519"},{"key":"777_CR30","doi-asserted-by":"crossref","unstructured":"Zhou Q, Fu Z, Gong Y, Seshachalam VP, Li J, Ma Y, et al. Metabolic Health Status Contributes to Transcriptome Alternation in Human Visceral Adipose Tissue During Obesity. Obesity (Silver Spring). 2020 Nov 1 [cited 2025 Feb 13];28(11):2153\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32985130\/","DOI":"10.1002\/oby.22950"},{"key":"777_CR31","doi-asserted-by":"crossref","unstructured":"Adam S, Maas SL, Huchzermeier R, Rakateli L, Abschlag K, Hohl M, et al. The calcium-sensing-receptor (CaSR) in adipocytes contributes to sex-differences in the susceptibility to high fat diet induced obesity and atherosclerosis. EBioMedicine. 2024 Sep 1 [cited 2025 Feb 13];107. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39146692\/","DOI":"10.1016\/j.ebiom.2024.105293"},{"key":"777_CR32","doi-asserted-by":"crossref","unstructured":"Davis KE, D. Neinast M, Sun K, M. Skiles W, D. Bills J, A. Zehr J, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Meta. 2013 Aug [cited 2025 Feb 13];2(3):227\u201342. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24049737\/","DOI":"10.1016\/j.molmet.2013.05.006"},{"key":"777_CR33","doi-asserted-by":"crossref","unstructured":"Bracht JR, Vieira-Potter VJ, De Souza Santos R, \u00d6z OK, Palmer BF, Clegg DJ. The role of estrogens in the adipose tissue milieu. Ann N Y Acad Sci. 2020 [cited 2025 Feb 13];1461(1):127\u201343. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31868931\/","DOI":"10.1111\/nyas.14281"},{"key":"777_CR34","doi-asserted-by":"crossref","unstructured":"Fatima LA, Campello RS, Santos RDS, Freitas HS, Frank AP, Machado UF, et al. Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue. Sci Rep. 2017 Dec 1 [cited 2025 Feb 13];7(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29196658\/","DOI":"10.1038\/s41598-017-16686-7"},{"key":"777_CR35","doi-asserted-by":"crossref","unstructured":"Davis KE, D. Neinast M, Sun K, M. Skiles W, D. Bills J, A. Zehr J, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013 Aug [cited 2025 Feb 13];2(3):227\u201342. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24049737\/","DOI":"10.1016\/j.molmet.2013.05.006"},{"key":"777_CR36","doi-asserted-by":"crossref","unstructured":"Zhou H, Patel V, Rice R, Lee R, Kim HW, Weintraub NL, et al. Neddylation and Its Target Cullin 3 Are Essential for Adipocyte Differentiation. Cells. 2024 Oct 1 [cited 2025 Feb 13];13(19). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39404417\/","DOI":"10.3390\/cells13191654"},{"key":"777_CR37","doi-asserted-by":"crossref","unstructured":"Satyanarayana A, Klarmann KD, Gavrilova O, Keller JR. Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis. FASEB J. 2012 Jan [cited 2025 Feb 13];26(1):309\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21990377\/","DOI":"10.1096\/fj.11-190892"},{"key":"777_CR38","doi-asserted-by":"crossref","unstructured":"Ruggiero AD, Key CCC, Kavanagh K. Adipose Tissue Macrophage Polarization in Healthy and Unhealthy Obesity. Front Nutr. 2021 Feb 17 [cited 2025 Mar 20];8:625331. Available from: www.frontiersin.org","DOI":"10.3389\/fnut.2021.625331"},{"key":"777_CR39","doi-asserted-by":"publisher","unstructured":"Khan T, Muise ES, Iyengar P, Wang Z V., Chandalia M, Abate N, et al. Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI. Mol Cell Biol. 2009 Mar 1 [cited 2025 Mar 20];29(6):1575\u201391. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.1128\/MCB.01300-08","DOI":"10.1128\/MCB.01300-08"},{"key":"777_CR40","doi-asserted-by":"crossref","unstructured":"Carobbio S, Pellegrinelli V, Vidal-Puig A. Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome. Adv Exp Med Biol. 2017 [cited 2025 Mar 20];960:161\u201396. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28585199\/","DOI":"10.1007\/978-3-319-48382-5_7"},{"key":"777_CR41","doi-asserted-by":"crossref","unstructured":"Chouchani ET, Kajimura S. Metabolic adaptation and maladaptation in adipose tissue. Nat Metab. 2019 Feb 1 [cited 2025 Mar 20];1(2):189\u2013200. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31903450\/","DOI":"10.1038\/s42255-018-0021-8"},{"key":"777_CR42","doi-asserted-by":"crossref","unstructured":"Guzm\u00e1n-Ruiz R, Tercero-Alc\u00e1zar C, Rabanal-Ruiz Y, D\u00edaz-Ruiz A, El Bekay R, Rangel-Zu\u00f1iga OA, et al. Adipose tissue depot-specific intracellular and extracellular cues contributing to insulin resistance in obese individuals. FASEB J. 2020 Jun 1 [cited 2025 Mar 20];34(6):7520\u201339. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32293066\/","DOI":"10.1096\/fj.201902703R"},{"key":"777_CR43","doi-asserted-by":"publisher","unstructured":"Kawai T, Autieri M V., Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021 Mar 1 [cited 2025 Mar 20];320(3):C375\u201391. Available from: https:\/\/journals.physiology.org\/doi\/https:\/\/doi.org\/10.1152\/ajpcell.00379.2020","DOI":"10.1152\/ajpcell.00379.2020"},{"key":"777_CR44","doi-asserted-by":"crossref","unstructured":"Hu Y, Zhang Y, Han P, Pan Y, Liu J, Li Y, et al. Machine learning-driven prediction of readmission risk in heart failure patients with diabetes: synergistic assessment of inflammatory and metabolic biomarkers. Int J Cardiol. 2025 Dec 15 [cited 2025 Sep 11];441. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40784376\/","DOI":"10.1016\/j.ijcard.2025.133743"},{"issue":"330","key":"777_CR45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cellimm.2018.03.001","volume":"1","author":"L Catrysse","year":"2018","unstructured":"Catrysse L, van Loo G. Adipose tissue macrophages and their polarization in health and obesity. Cell Immunol. 2018;1(330):114\u20139.","journal-title":"Cell Immunol"},{"key":"777_CR46","doi-asserted-by":"crossref","unstructured":"Guria S, Hoory A, Das S, Chattopadhyay D, Mukherjee S. Adipose tissue macrophages and their role in obesity-associated insulin resistance: an overview of the complex dynamics at play. Biosci Rep. 2023 Mar 1 [cited 2025 Mar 20];43(3):20220200. Available from: \/bioscirep\/article\/43\/3\/BSR20220200\/232519\/Adipose-tissue-macrophages-and-their-role-in","DOI":"10.1042\/BSR20220200"},{"key":"777_CR47","doi-asserted-by":"crossref","unstructured":"Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017 Jan 3 [cited 2025 Mar 20];127(1):74\u201382. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28045400\/","DOI":"10.1172\/JCI88883"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00777-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-025-00777-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-025-00777-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T14:49:38Z","timestamp":1762440578000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-025-00777-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/s13293-025-00777-6","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol has been approved by the Hospital Universitario de Getafe Ethical Committee (CEIm 18\/30) and carried out in accordance with the Declaration of Helsinki (Code of Ethics of the World Medical Association) for experiments that involved humans. All study participants signed informed consent after being clearly informed about the purpose of this research protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}